Skip to main content

. 1954 Feb;139(2):137–142. doi: 10.1097/00000658-195402000-00002

Dextran as a Plasma Substitute with Plasma Volume and Excretion Studies on Control Patients ^{^*}

J Harold Harrison

PMCID: PMC1609372 PMID: 13125244

137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BLOOM W. L. Present status of plasma volume expanders in the treatment of shock; clinical laboratory studies. AMA Arch Surg. 1951 Dec;63(6):739–741. doi: 10.1001/archsurg.1951.01250040755004. [DOI] [PubMed] [Google Scholar]
GRAY I., SIITERI P. K., PULASKI E. J. Metabolism of plasma substitute. I. Dextran (Macrodex). Proc Soc Exp Biol Med. 1951 Aug;77(4):626–627. doi: 10.3181/00379727-77-18870. [DOI] [PubMed] [Google Scholar]
Gibson J. G., Evans W. A. CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER. J Clin Invest. 1937 May;16(3):301–316. doi: 10.1172/JCI100859. [DOI] [PMC free article] [PubMed] [Google Scholar]
HARTMAN F. W. Tissue changes following the use of plasma substitutes. AMA Arch Surg. 1951 Dec;63(6):728–738. doi: 10.1001/archsurg.1951.01250040744003. [DOI] [PubMed] [Google Scholar]
NELSON A. A., LUSKY L. M. Pathological changes in rabbits from repeated intravenous injections of periston (polyvinyl pyrrolidone) or dextran. Proc Soc Exp Biol Med. 1951 Apr;76(4):765–767. doi: 10.3181/00379727-76-18626. [DOI] [PubMed] [Google Scholar]
WITHAM A. C., FLEMING J. W., BLOOM W. L. The effect of the intravenous administration of dextran on cardiac output and other circulatory dynamics. J Clin Invest. 1951 Sep;30(9):897–902. doi: 10.1172/JCI102509. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES